Global Medicare · Endometrial Program
When implantation keeps failing, understanding the endometrium matters.
A specialist evaluation pathway for women seeking another review of endometrial factors, including thin or atrophic endometrium, Asherman syndrome after adhesiolysis, treated chronic endometritis, adenomyosis, repeated implantation failure or recurrent pregnancy loss.
Global Medicare provides initial orientation and coordination. Clinical interpretation, treatment decisions and research eligibility remain with the authorised medical and research teams.
Start with your situation
Does this sound familiar?
Endometrial factors can form part of a complex fertility history. Another specialist review may help clarify what should be considered next.
These situations do not establish a diagnosis, treatment recommendation or research eligibility.
When previous attempts have not answered the question
When implantation remains difficult, the endometrial context may deserve another specialist review.
Previous unsuccessful transfers, a persistently thin endometrium or a complex endometrial history may justify an individual specialist assessment before deciding what to do next.
No improvement, implantation or pregnancy outcome can be guaranteed.
The Endometrial Program
From your history to specialist assessment.
A structured pathway designed to separate patient orientation, clinical decisions and research.
Your history
Tell us why you are seeking another endometrial review.
Initial orientation
Global Medicare helps organise the appropriate next step.
Specialist assessment
Relevant clinical information is reviewed by the medical team.
Clinical decision
Treatment decisions remain independent from research participation.
Research when applicable
The 03-REGEN-AR research pathway is considered only when appropriate.
Science
Understanding endometrial development.
The endometrial research framework at IVF Baden-Baden compares clinical outcomes observed with two autologous preparations: Standard-PRP and IAS.
The study focuses principally on endometrial development, especially endometrial thickness. The clinical choice between Standard-PRP and IAS is made independently from participation in research.
IAS is an autologous preparation with an additional processing step. It should not be presented as purified exosome therapy or as superior to Standard-PRP.
Clinical & Research Centre
Baden-Baden
Specialist endometrial evaluation within an established clinical pathway.
The 03-REGEN-AR endometrial observational study is conducted at IVF Baden-Baden in Germany.
Clinical care and research participation are separate. Participation in the Endometrial Program does not guarantee participation in 03-REGEN-AR.
RegenEndo
Study 03-REGEN-ARRegenEndo is the endometrial research program associated with study 03-REGEN-AR at IVF Baden-Baden. The observational study prospectively documents and compares endometrial parameters in patients receiving Standard-PRP or IAS within routine clinical care.
thickness key primary comparison parameter
RegenEndo refers to the endometrial research program. The formal study identifier is 03-REGEN-AR. This information does not confirm research eligibility or constitute an invitation to participate. Final eligibility belongs to the authorised medical and research teams.
Initial orientation
Tell us a little about your situation.
A few general questions can help organise the next step towards an endometrial specialist review.
Important questions
Clear information before your next step.
Understand where general orientation ends and individual medical assessment begins.
Does this page confirm whether I am eligible for 03-REGEN-AR?
Can Global Medicare interpret my endometrial thickness?
Is 6.5 mm an automatic decision threshold?
Is IAS considered better than Standard-PRP?
Does participation in research guarantee an improvement or pregnancy?
Your next step
Another specialist review starts with understanding your history.
If your fertility journey involves thin endometrium, implantation failure, Asherman syndrome, treated chronic endometritis, adenomyosis or recurrent pregnancy loss, Global Medicare can help organise the initial orientation pathway.